Close
Almac
Achema middle east

Articles

Rivaroxaban plus aspirin improves outcomes in stable cardiovascular disease (COMPASS)

Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line – LBCT Session at ESC...

Innovative oral dissolving CureFilm moves drug delivery platforms into the future

CURE Pharmaceutical has developed innovative drug delivery technology in CureFilm, an oral film strip that dissolves in the mouth, allows for multiple active ingredients in one dosage, and features higher bioavailability. CureFilm is the next generation market alternative to traditional...

Smart Sourcing Strategy for Safety & Risk Management – How to Select the Right Vendor

Life Science companies, both large and small, are seeking more strategic partnerships with vendors. As they expand into new geographies, markets and regions, or consolidate operations due to mergers and acquisitions, specialised capabilities and regulatory knowledge are a critical consideration...

Contract ManufacturingOrganizations: Navigating Serialization Implementation

In recent years the pharmaceutical industry has seen a significant change to the way its manufacturersand supply chains operate, due to the establishment of several serialization and track and trace regulations mandated globally. The prominent driving force behind such regulations...

The Way Forward For Drug Delivery Technology

1. What makes the market demand rising for integrated delivery system? The market demand for integrated delivery systems which combine an injectable drug, its container and the system used to administer it—continues to grow due, in large part, to the...

Driving Patient Engagement in Alzheimer’s Disease Clinical Research to Achieve Trial Success

Worldwide, around 47 million people have dementia, and there are 9.9 million new cases every year, according to recent data from the World Health Organization (WHO)1.Alzheimer's disease (AD) is the most common cause of dementia and may contribute to...

Solving Challenges and Pain Points for Complex Global Clinical Trials

Clinical trials are evolving away from trials based solely at investigator sites, moving on to the patient’s home, requiring direct-to-patient services in order for patients to participate. Homecare networks are now responsible for not only patient treatment, but also for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »